Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Yang

Showing results (11-20 of 156) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2019
Mutated RAS: Targeting the "Untargetable" with T CellsPraveen D Chatani, James C Yang
Journal of Molecular Medicine (Berlin, Germany)|March 11, 2005
Novel biochemistry: post-translational protein splicing and other lessons from the school of antigen processingKen-ichi Hanada, James C Yang
Advances in Immunology|March 1, 2016
Adoptive T-Cell Therapy for CancerJames C Yang, Steven A Rosenberg
Nature Reviews. Clinical Oncology|October 15, 2014
MSLT-I-response of clinical trial investigatorsJames C Yang, Richard M Sherry
Surgical Oncology Clinics of North America|May 14, 2019
Adoptive T-Cell Therapy for Solid MalignanciesMohammad S Jafferji, James C Yang
The Oncologist|July 16, 2024
Lifileucel: FDA-approved T-cell therapy for melanomaMei Li M Kwong, James C Yang
Seminars in Radiation Oncology|March 28, 2006
Treatment of oligometastases after successful immunotherapyJames C Yang, John Abad, Richard Sherry
Nature Medicine|September 2, 2004
Cancer immunotherapy: moving beyond current vaccinesSteven A Rosenberg, James C Yang, Nicholas P Restifo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Adoptive T-cell transfer therapy and oncogene-targeted therapy for melanoma: the search for synergyMei Li M Kwong, Bart Neyns, James C Yang
Nature Reviews. Clinical Oncology|April 16, 2014
Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma?James C Yang, Richard M Sherry, Steven A Rosenberg
Pageof 16

Showing results (11-20 of 156) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2019
Mutated RAS: Targeting the "Untargetable" with T CellsPraveen D Chatani, James C Yang
Journal of Molecular Medicine (Berlin, Germany)|March 11, 2005
Novel biochemistry: post-translational protein splicing and other lessons from the school of antigen processingKen-ichi Hanada, James C Yang
Advances in Immunology|March 1, 2016
Adoptive T-Cell Therapy for CancerJames C Yang, Steven A Rosenberg
Nature Reviews. Clinical Oncology|October 15, 2014
MSLT-I-response of clinical trial investigatorsJames C Yang, Richard M Sherry
Surgical Oncology Clinics of North America|May 14, 2019
Adoptive T-Cell Therapy for Solid MalignanciesMohammad S Jafferji, James C Yang
The Oncologist|July 16, 2024
Lifileucel: FDA-approved T-cell therapy for melanomaMei Li M Kwong, James C Yang
Seminars in Radiation Oncology|March 28, 2006
Treatment of oligometastases after successful immunotherapyJames C Yang, John Abad, Richard Sherry
Nature Medicine|September 2, 2004
Cancer immunotherapy: moving beyond current vaccinesSteven A Rosenberg, James C Yang, Nicholas P Restifo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2013
Adoptive T-cell transfer therapy and oncogene-targeted therapy for melanoma: the search for synergyMei Li M Kwong, Bart Neyns, James C Yang
Nature Reviews. Clinical Oncology|April 16, 2014
Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma?James C Yang, Richard M Sherry, Steven A Rosenberg
Pageof 16